Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.577
Abstract: New therapeutic strategies are urgently needed to improve clinical outcomes in patients with multiple myeloma (MM). Daratumumab is a first‐in‐class, CD38 human immunoglobulin G1κ monoclonal antibody approved for treatment of relapsed or refractory MM. Identification… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "SLEEP"
DOI: 10.1093/sleep/zsad077.0591
Abstract: Lower-sodium oxybate (LXB, Xywav®) contains 92% less sodium than higher-sodium oxybate (SXB, Xyrem®) and is approved for treating cataplexy or excessive daytime sleepiness in patients with narcolepsy (≥7 years of age) and idiopathic hypersomnia in… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13717
Abstract: The initial tacrolimus dose regimen in paediatric lung transplant recipients is unknown. The present study optimized the initial tacrolimus dose regimen for paediatric lung transplant recipients. read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5046
Abstract: Background Methotrexate (MTX) is a well-known anchor drug for rheumatoid arthritis (RA); however, dose regimens vary. We previously reported in EULAR2015 that split dose weekly oral methotrexate induced elevation of AST and ALT in association… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-050507
Abstract: Objective To compare the efficacy and safety of alternative glucocorticoids (GCs) regimens as induction therapy for patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Design Systematic review of randomised controlled trials (RCTs). Data sources Medline, Embase,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-020-05097-1
Abstract: Background Despite the existence of a population-based control program using single dose albendazole or mebendazole as a preventive chemotherapy, hookworm transmission remains high. It causes a negative impact on the growth and school performance of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11060798
Abstract: Colistin methanesulfonate (CMS) is an important treatment option for infections caused by carbapenem-resistant Gram-negative organisms (CROs). This study evaluated the pharmacokinetic/pharmacodynamic (PK/PD) profiles and safety of CMS in Chinese subjects following a recommended dosage. A… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Toxics"
DOI: 10.3390/toxics10040190
Abstract: Humans are exposed to xenobiotic mixtures daily through the long-term, low-dose regimen. Investigations designed to simulate this exposure profile approach the real-life risk simulation (RLRS) idea of modern toxicology. The purpose of the present study… read more here.